Medtronic appoints Lidia Fonseca to board, effective June 27, 2022

Medtronic plc

Board increased from 10 to 11 directors; Fonseca appointed as independent director.
Fonseca is EVP, Chief Digital & Technology Officer at Pfizer with 30+ years healthcare IT experience.
She will serve on Compensation and Science & Technology Committees.
At Pfizer she led digital acceleration of COVID-19 vaccine and advanced analytics platform.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Lidia L. Fonseca

Director

MDT · Medtronic plc

Effective: 2022-06-27
Filed: June 27, 2022, 7:59 PM ET

the Board of Directors (Board) of Medtronic plc (Company) increased the size of the Board from 10 to 11 and appointed Lidia L. Fonseca as a new director of the Company, in each case effective as of June 27, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Lidia L. Fonseca was appointed as Director at Medtronic plc.

Action: appointed
Role: Director

Exact text from the filing

the Board of Directors (Board) of Medtronic plc (Company) increased the size of the Board from 10 to 11 and appointed Lidia L. Fonseca as a new director of the Company, in each case effective as of June 27, 2022.

View on SEC.gov

Medtronic plc filing history →

Source: SEC EDGAR

accession 0001613103-22-000027

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.